PAH: Phenylalanine-4-hydroxylase
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Catalyzes the hydroxylation of L-phenylalanine to L-tyrosine. .
- Drugs that act on it: 1
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Drug | US approval | Mechanism | Action | Warnings |
|---|---|---|---|---|
| Sapropterin | Approved | Phenylalanine-4-hydroxylase activator | Activator | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Phenylketonuria
- 0.89
- Hyperphenylalaninemia due to tetrahydrobiopterin deficiency
- 0.68
- Hereditary disease
- 0.55
- BH4-deficient hyperphenylalaninemia A
- 0.54
- Pulmonary hypertension, primary, 1
- 0.46
- Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis
- 0.42
- Mild hyperphenylalaninemia
- 0.38
- Malnutrition
- 0.37
- Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria
- 0.37
- Maternal phenylketonuria
- 0.37
- Combined pituitary hormone deficiencies, genetic form
- 0.35
- Breast cancer
- 0.34
Drugs and mechanisms are from ChEMBL CHEMBL3076 (CC BY-SA 3.0). Gene name, function (UniProt P00439, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets